Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients. [electronic resource]
Producer: 20060522Description: 84-90 p. digitalISSN:- 0360-3016
- Acyclovir -- analogs & derivatives
- Adenoviridae -- genetics
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Antiviral Agents -- therapeutic use
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Combined Modality Therapy -- methods
- Genetic Therapy -- methods
- Humans
- Immunity, Cellular
- Killer Cells, Natural -- immunology
- Male
- Middle Aged
- Prostatic Neoplasms -- immunology
- Radiotherapy, Intensity-Modulated
- Thymidine Kinase -- administration & dosage
- Valacyclovir
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.